about
RANKL promotes migration and invasion of hepatocellular carcinoma cells via NF-κB-mediated epithelial-mesenchymal transition.RYBP expression is associated with better survival of patients with hepatocellular carcinoma (HCC) and responsiveness to chemotherapy of HCC cells in vitro and in vivo.Inferring the progression of multifocal liver cancer from spatial and temporal genomic heterogeneity.Protein tyrosine phosphatase PTP4A1 promotes proliferation and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma via the PI3K/AKT pathway.Cell Culture System for Analysis of Genetic Heterogeneity Within Hepatocellular Carcinomas and Response to Pharmacologic Agents.Overexpression of protein O-fucosyltransferase 1 accelerates hepatocellular carcinoma progression via the Notch signaling pathway.CC chemokine receptor-like 1 functions as a tumour suppressor by impairing CCR7-related chemotaxis in hepatocellular carcinoma.Activating mutations in PTPN3 promote cholangiocarcinoma cell proliferation and migration and are associated with tumor recurrence in patients.Clinical significance of the ubiquitin ligase UBE3C in hepatocellular carcinoma revealed by exome sequencing.CXCR6 upregulation contributes to a proinflammatory tumor microenvironment that drives metastasis and poor patient outcomes in hepatocellular carcinoma.FOXP3 Is a HCC suppressor gene and Acts through regulating the TGF-β/Smad2/3 signaling pathway.Telomere Length Variation in Tumor cells and Cancer-Associated Fibroblasts: Potential Biomarker for Hepatocellular Carcinoma.Protein glycosylation in viral hepatitis-related HCC: Characterization of heterogeneity, biological roles, and clinical implications.Hepatocellular carcinoma 20 mm or smaller in cirrhosis patients: early magnetic resonance enhancement by gadoxetic acid compared with gadopentetate dimeglumine.Co-expression of PKM2 and TRIM35 predicts survival and recurrence in hepatocellular carcinoma.An X-chromosomal association study identifies a susceptibility locus at Xq22.1 for hepatitis B virus-related hepatocellular carcinoma.Margin-infiltrating CD20(+) B cells display an atypical memory phenotype and correlate with favorable prognosis in hepatocellular carcinoma.A New Preoperative Prognostic System Combining CRP and CA199 For Patients with Intrahepatic Cholangiocarcinoma.Diverse modes of clonal evolution in HBV-related hepatocellular carcinoma revealed by single-cell genome sequencing.Critical appraisal of Chinese 2017 guideline on the management of hepatocellular carcinoma.Naive Treg-like CCR7(+) mononuclear cells indicate unfavorable prognosis in hepatocellular carcinoma.Efficacy and Safety of Transcatheter Arterial Chemoembolization and Transcatheter Arterial Chemotherapy Infusion in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.Infiltrating memory/senescent T cell ratio predicts extrahepatic metastasis of hepatocellular carcinoma.TREM-1, an inflammatory modulator, is expressed in hepatocellular carcinoma cells and significantly promotes tumor progression.Ubiquitin-specific protease 7 accelerates p14(ARF) degradation by deubiquitinating thyroid hormone receptor-interacting protein 12 and promotes hepatocellular carcinoma progression.HNRNPAB induces epithelial-mesenchymal transition and promotes metastasis of hepatocellular carcinoma by transcriptionally activating SNAIL.CK7/CK19 index: A potential prognostic factor for postoperative intrahepatic cholangiocarcinoma patientsRadiomics score: a potential prognostic imaging feature for postoperative survival of solitary HCC patientsTumor stroma reaction-related gene signature predicts clinical outcome in human hepatocellular carcinomaMultiple carcinogenesis contributes to the heterogeneity of HCCHeterogeneity of intermediate-stage HCC necessitates personalized management including surgeryThe distribution of immune cells within combined hepatocellular carcinoma and cholangiocarcinoma predicts clinical outcome
P50
Q34277337-352DDE41-2D4A-46CF-AA26-AC6D3686CA7FQ34956767-D7EC3C71-8388-45C2-8D6D-6BEF240D89FBQ36771967-1A57B54D-01F1-4005-9D0D-244BCFCA569DQ37688923-033AED51-1D7E-4014-90CB-C98FA4C055F8Q38745776-08CBC070-3143-4755-A980-654D9F498E39Q38784125-91A99771-C48C-498E-9ED2-46AAD0F8F976Q38953360-BFE01733-DEB9-4CE9-BC49-469F0777C420Q39026508-5A105703-5EC9-46AC-8C1E-C7F40B953C26Q39034333-CEBADF7D-1F61-4B73-80B9-3F2CC49A5FE0Q39329091-C0448948-30C3-4AF8-AADD-FF939A6E5E8BQ40042902-A6F2AA39-3F5B-4C9A-8CA1-D4E864E74D87Q40073868-E3D46DFE-5542-4FEC-960B-8F655146FEEFQ40090173-23E2189D-94B5-40D1-9BD2-78610864CE07Q40706063-69223F3B-1E94-4DC9-B741-D61D575BE721Q41597501-2A7A88D1-F3AB-4144-AF63-0E9305F4F255Q42256879-BA2BE4CA-F285-4B54-9D6C-69E8405C2E56Q44177139-216CA3A8-2796-445E-8A12-656CE8CCDC25Q45851469-7B577804-2D75-4D44-B77A-3A8EF599F352Q47554590-D76AA71F-F603-44B8-BD29-F6201C63C4EAQ47566919-FAD0C9FC-8CAC-44DE-9F71-8E01CDEB623EQ48631423-546A37AE-5C30-4026-B738-DCCF6F48FFD7Q50087137-070C41E5-067C-48A3-97AF-A8603C71C0AEQ50998467-CAE61BB4-0490-4CBF-A689-620D70E639DEQ52997142-472CC535-A4A0-460D-A86E-BB050291A365Q53225430-FE80F7B5-2A46-430B-B997-18F52FF20DDFQ53240716-67E87BFD-03BD-4A76-8BD2-E0C933769B1DQ57118446-9D41A978-7EA0-45D9-BB04-8DC80A321373Q59336080-7794B191-F4F0-459F-B0D9-FAEDD9DE8CC0Q84081961-EDC50B99-9844-4FF1-B9AE-212D8E1D2078Q86048662-8B9646B9-F101-46AD-8B27-0D820FC0213BQ95607160-761C6F53-E1B4-4AE0-9E5B-89442DD2D0F2Q96166991-7C70E184-58B5-42A9-8E15-3A88A74630D7
P50
description
onderzoeker
@nl
researcher ORCID: 0000-0002-6695-9906
@en
name
Qiang Gao
@ast
Qiang Gao
@en
Qiang Gao
@es
Qiang Gao
@nl
type
label
Qiang Gao
@ast
Qiang Gao
@en
Qiang Gao
@es
Qiang Gao
@nl
prefLabel
Qiang Gao
@ast
Qiang Gao
@en
Qiang Gao
@es
Qiang Gao
@nl
P108
P106
P31
P496
0000-0002-6695-9906